CD47-SIRPα Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer.
J Immunol Res
; 2020: 9435030, 2020.
Article
in En
| MEDLINE
| ID: mdl-33015199
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Immunologic
/
Antigens, Differentiation
/
Biomarkers, Tumor
/
Carcinoma, Non-Small-Cell Lung
/
CD47 Antigen
/
Lung Neoplasms
Type of study:
Etiology_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Immunol Res
Year:
2020
Document type:
Article
Affiliation country:
Mexico
Country of publication:
Egypt